NOVONIX Files 6-K Report
Ticker: NVNXF · Form: 6-K · Filed: Sep 20, 2024 · CIK: 1859795
Sentiment: neutral
Topics: reporting, foreign-private-issuer
TL;DR
NOVONIX filed a 6-K, but it's just an appendix for now.
AI Summary
NOVONIX Limited filed a Form 6-K on September 20, 2024, reporting for the month of September 2024. The filing includes Appendix 2A, which is an application, but no specific financial figures or operational updates are detailed in the provided text.
Why It Matters
This filing indicates ongoing reporting requirements for NOVONIX Limited as a foreign private issuer, but lacks specific operational or financial details in the provided excerpt.
Risk Assessment
Risk Level: low — The filing is a routine report and does not contain information that suggests immediate risk or significant changes.
Key Players & Entities
- NOVONIX Limited (company) — Registrant
- September 20, 2024 (date) — Filing date
- Appendix 2A (document) — Included exhibit
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of September 2024.
What specific exhibits are included in this filing?
The filing includes Exhibit 99.1, which is described as Appendix 2A (Application).
Does NOVONIX Limited file its annual reports under Form 20-F or 40-F?
NOVONIX Limited indicates it files its annual reports under cover of Form 20-F.
What is the principal executive office address for NOVONIX Limited?
The principal executive office is located at Level 38, 71 Eagle Street, Brisbane, QLD 4000, Australia.
What is the SIC code for NOVONIX Limited?
The Standard Industrial Classification (SIC) code for NOVONIX Limited is 3690, which corresponds to Miscellaneous Electrical Machinery, Equipment & Supplies.
Filing Stats: 202 words · 1 min read · ~1 pages · Grade level 12.6 · Accepted 2024-09-20 17:00:02
Filing Documents
- nvx-6k-sep-24-09-19-app2.htm (6-K) — 19KB
- nvx-ex99_1.htm (EX-99.1) — 79KB
- nvx-ex99_2.htm (EX-99.2) — 42KB
- img58969013_0.jpg (GRAPHIC) — 1KB
- 0000950170-24-108454.txt ( ) — 143KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NOVONIX LIMITED By: /s/ Dr. John Christopher Burns Dr. John Christopher Burns Chief Executive Officer Date: September 19, 2024